Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the relative bioavailability of the test
formulation of furosemide 80 mg tablets (Ohm Laboratories, Inc.) with an already marketed
reference formulation Lasix® (furosemide) 80 mg tablets (Aventis Pharmaceuticals NJ) under
fasted conditions in healthy adult human subjects